Answers are grounded in this paper and cite their sources.
Dravet syndrome is a rare, early childhood-onset epileptic and developmental encephalopathy. Responses to placebo in clinical trials for epilepsy therapies range widely, but factors influencing placebo response remain poorly understood. This study explored placebo response and its effects on safety, efficacy, and quality of life outcomes in patients with Dravet syndrome.
No takes yet. Share an insight, caveat, or question.
Devinsky et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: